Literature DB >> 9841504

Estradiol reverses TGF-beta1-stimulated type IV collagen gene transcription in murine mesangial cells.

S Silbiger1, J Lei, F N Ziyadeh, J Neugarten.   

Abstract

We have previously shown that estradiol suppresses types I and IV collagen synthesis by mesangial cells grown in the presence of serum. In the present study, we examined the interaction between estradiol and transforming growth factor-beta (TGF-beta) on collagen IV synthesis. In a luciferase reporter gene construct containing the type IV collagen promoter and 1-chain regulatory sequences, we found that TGF-beta1 (2 ng/ml) stimulated alpha1-collagen IV gene transcription in serum-free media (140.5 +/- 6.2 relative luciferase units, expressed as a percent of control untreated cells, P < 0.001). Estradiol reversed the stimulatory effects of TGF-beta1 on reporter gene transcription in a dose-dependent manner [for 2.5 x 10(-9) M, 114.2 +/- 0.2, P < 0.002 vs. TGF-beta1; for 10(-7) M, 89.5 +/- 4.0, P < 0.001 vs. TGF-beta1 and P = not significant (NS) vs. control]. Using immunoprecipitation techniques, we found that estradiol (10(-7) M) reversed TGF-beta1-stimulated type IV collagen synthesis (175.3 +/- 14.7 vs. 111.6 +/- 7.1, expressed as a percent of control untreated cells, P < 0.001) but did not affect TGF-beta1-stimulated type I collagen synthesis (166.9 +/- 18.8 vs. 162.2 +/- 16.2, P = NS). These results were confirmed with Western blotting. Nuclear extracts from mesangial cells treated with TGF-beta1 showed increased binding to a Sp1 consensus binding sequence oligonucleotide and to an Sp1 binding site in the collagen IV promoter. Estradiol reversed this enhanced binding. These data suggest that estradiol antagonizes TGF-beta1-stimulated type IV collagen synthesis at a transcriptional level and that this effect may be mediated by interactions with the transcription factor Sp1.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9841504     DOI: 10.1152/ajprenal.1998.274.6.F1113

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  18 in total

Review 1.  Effects of gender on the renin-angiotensin system, blood pressure, and renal function.

Authors:  Amrit K Kang; Judith A Miller
Journal:  Curr Hypertens Rep       Date:  2002-04       Impact factor: 5.369

Review 2.  Estrogen-TGFbeta cross-talk in bone and other cell types: role of TIEG, Runx2, and other transcription factors.

Authors:  J R Hawse; M Subramaniam; J N Ingle; M J Oursler; N M Rajamannan; T C Spelsberg
Journal:  J Cell Biochem       Date:  2008-02-01       Impact factor: 4.429

3.  Differential effects of continuous and intermittent 17beta-estradiol replacement and tamoxifen therapy on the prevention of glomerulosclerosis: modulation of the mesangial cell phenotype in vivo.

Authors:  Michael Karl; Mariana Berho; Judith Pignac-Kobinger; Gary E Striker; Sharon J Elliot
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

4.  Stable Isotope Labeling with Amino Acids (SILAC)-Based Proteomics of Primary Human Kidney Cells Reveals a Novel Link between Male Sex Hormones and Impaired Energy Metabolism in Diabetic Kidney Disease.

Authors:  Sergi Clotet; Maria Jose Soler; Marta Riera; Julio Pascual; Fei Fang; Joyce Zhou; Ihor Batruch; Stella K Vasiliou; Apostolos Dimitromanolakis; Clara Barrios; Eleftherios P Diamandis; James W Scholey; Ana Konvalinka
Journal:  Mol Cell Proteomics       Date:  2017-01-04       Impact factor: 5.911

5.  Estrogen and raloxifene, a selective estrogen receptor modulator, ameliorate renal damage in db/db mice.

Authors:  Masami Chin; Motohide Isono; Keiji Isshiki; Shin-ichi Araki; Toshiro Sugimoto; Baoliang Guo; Haruhisa Sato; Masakazu Haneda; Atsunori Kashiwagi; Daisuke Koya
Journal:  Am J Pathol       Date:  2005-06       Impact factor: 4.307

Review 6.  Changes in renal hemodynamics and structure in the aging kidney; sexual dimorphism and the nitric oxide system.

Authors:  Chris Baylis
Journal:  Exp Gerontol       Date:  2005-04       Impact factor: 4.032

7.  Podocyte injury and albuminuria in mice with podocyte-specific overexpression of the Ste20-like kinase, SLK.

Authors:  Andrey V Cybulsky; Tomoko Takano; Joan Papillon; Julie Guillemette; Andrew M Herzenberg; Chris R J Kennedy
Journal:  Am J Pathol       Date:  2010-10-01       Impact factor: 4.307

8.  Transforming growth factor beta1-induced glomerulopathy is prevented by 17beta-estradiol supplementation.

Authors:  Camilla Birch Nielsen; Søren Krag; Ruth ØSterby; Allan Flyvbjerg; Jens Nyengaard; Axel Forman; Lise Wogensen
Journal:  Virchows Arch       Date:  2004-04-24       Impact factor: 4.064

9.  Estradiol, TGF-β1 and hypoxia promote breast cancer stemness and EMT-mediated breast cancer migration.

Authors:  Seong-Joon Park; Joong-Gook Kim; Nam Deuk Kim; Kwangmo Yang; Jae Woong Shim; Kyu Heo
Journal:  Oncol Lett       Date:  2016-01-15       Impact factor: 2.967

10.  Hormone therapy and urine protein excretion: a multiracial cohort study, systematic review, and meta-analysis.

Authors:  Andrea G Kattah; Maria L G Suarez; Natasa Milic; Kejal Kantarci; Burcu Zeydan; Thomas Mosley; Stephen T Turner; Erin B Ware; Sharon L R Kardia; Vesna D Garovic
Journal:  Menopause       Date:  2018-06       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.